press_release_conclusion: Scientists including those from Queen’s University have discovered that taking regular aspirin halves the risk of developing hereditary cancers.
abstract_conclusion: 600 mg aspirin per day for a mean of 25 months substantially reduced cancer incidence after 55·7 months in carriers of hereditary colorectal cancer.